Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AdaptHealth Corp (AHCO) vs Alibaba Group (BABA) Price & Performance

AdaptHealth CorpTrade
Alibaba GroupTrade

Price performance (Past 24H)

Key statistics

AdaptHealth Corp vs Alibaba Group — how do they compare? AdaptHealth Corp trades at $5.66 (market cap $759.10M), while Alibaba Group trades at $125.05 (market cap $309.65B). The key difference: Alibaba Group is far larger — about 407.9× AdaptHealth Corp's market cap, and Alibaba Group pays a 0.79% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.

AHCOBABA
Market Cap
$759.10M$309.65B
Sector
HealthConsumer Cyclical
52-Week High
$13.38$189.34
52-Week Low
$5.22$94.83
Enterprise Value
$2.78B$304.43B
Volume
18,069,938
Dividend Yield
0.79%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AdaptHealth Corp

AdaptHealth Corp. (AHCO) trades at $5.69, down 5.87% in the last 24 hours, reflecting negative sentiment after recent earnings misses and lowered guidance. The stock shows a bearish technical signal with support near $5, while fundamentals reveal revenue of $3.24 billion in 2025 but a net loss of $70.79 million, with profitability metrics like net margin at -6.82% indicating operational challenges. Recent news highlights multiple law firm investigations into potential securities fraud following disappointing Q2 2026 results.

The outlook for AHCO is cautious due to persistent earnings underperformance and rising costs from fixed-price contracts. While analyst consensus remains bullish with a $11.00 price target, significant risks include ongoing legal scrutiny, margin pressure, and execution uncertainties. Investors should weigh the high institutional buy ratings against fundamental weaknesses and recent negative developments.

Alibaba Group

Alibaba (BABA) trades at $128.41, up 1.26% today, with a bullish technical signal and strong analyst support. Recent earnings misses contrast with solid fundamentals: revenue grew to $996.35B in 2025, net income margin expanded to 13.05%, and valuation ratios like P/E of 19.7 appear reasonable. The company announced a $1.05 dividend for H1-26 and faces multiple class-action lawsuits filed in August 2026, alleging securities fraud between June 2025 and June 2026.

Outlook is mixed: bullish analyst consensus (86% buy ratings) and a $195 price target suggest upside, but legal risks and earnings volatility pose headwinds. Investment opportunity hinges on AI growth and cloud strength, while risks include litigation outcomes and competitive pressures in China.

Returns comparison

Trailing returns across standard periods

About AdaptHealth Corp

AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.

Read more on AHCO

About Alibaba Group

Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.

Read more on BABA